rs748496499
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_031427.4(DNAL1):c.43-4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000968 in 1,445,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031427.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAL1 | NM_031427.4 | c.43-4A>G | splice_region_variant, intron_variant | ENST00000553645.7 | NP_113615.2 | |||
DNAL1 | NM_001201366.2 | c.-75-4A>G | splice_region_variant, intron_variant | NP_001188295.1 | ||||
DNAL1 | XM_017021679.3 | c.-75-4A>G | splice_region_variant, intron_variant | XP_016877168.1 | ||||
DNAL1 | XM_024449715.2 | c.-75-4A>G | splice_region_variant, intron_variant | XP_024305483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAL1 | ENST00000553645.7 | c.43-4A>G | splice_region_variant, intron_variant | 1 | NM_031427.4 | ENSP00000452037.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000371 AC: 9AN: 242534Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131778
GnomAD4 exome AF: 0.00000968 AC: 14AN: 1445854Hom.: 0 Cov.: 29 AF XY: 0.00000695 AC XY: 5AN XY: 719346
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 16, 2019 | This sequence change falls in intron 2 of the DNAL1 gene. It does not directly change the encoded amino acid sequence of the DNAL1 protein. This variant is present in population databases (rs748496499, ExAC 0.04%). This variant has not been reported in the literature in individuals with a DNAL1-related disease. ClinVar contains an entry for this variant (Variation ID: 261960). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, this variant has uncertain impact on DNAL1 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at